Category: Boston Scientific
Vagus nerve stimulation for heart failure flunks a Boston Scientific clinical trial but passes a Cyberonics study, but the question is clouded by the more rigorous, sham-arm structure of the Boston Scientific trial.
Secant Medical is dismissed from hundreds of personal injury lawsuits brought over pelvic mesh it made for Boston Scientific and Johnson & Johnson.
Boston Scientific says it's closed the $415 million acquisition of Bayer AG's interventions unit, nearly doubling the size of its peripherals business.
Boston Scientific (NYSE:BSX) said today that it closed on the $415 million cash buyout of Bayer AG's interventional unit it announced last May.
The failure of Medtronic's Symplicity 3 trial doesn't mean the end of renal denervation in treated resistant hypertension, especially in Europe, but future studies face a high bar set by the Medtronic trial's sham control arm.
Boston Scientific reportedly wins the 2nd bellwether trial over its Obtryx pelvic mesh device, a month after winning the 1st personal injury case to go to trial over its transvaginal sling devices.
An FDA advisory panel is slated to convene yet again in October to consider the safety and efficacy of Boston Scientific's Watchman anti-stroke heart repair device.
Here's a look at some of the top legal news stories for medical device companies this week: Mirowski wants another bite at Supreme Court apple in Medtronic lawsuit; Shareholders sue InVivo Therapeutics, ex-CEO Reynolds over delayed FDA trial; Retractable Technologies urges appeals court to leave infringement win over BD alone; Boston Scientific can't sever Pinnacle pelvic mesh cases; Allergan can't delay shareholder vote on hostile Valeant bid